Adaptimmune Therapeutics Plc ROIC
What is the ROIC of Adaptimmune Therapeutics Plc?
The ROIC of Adaptimmune Therapeutics Plc is -36.80%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Adaptimmune Therapeutics Plc
What does Adaptimmune Therapeutics Plc do?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Companies with roic similar to Adaptimmune Therapeutics Plc
- ProQR Therapeutics N.V has ROIC of -37.03%
- Bambuser AB (publ) has ROIC of -36.99%
- ZoomAway Travel has ROIC of -36.98%
- Flower One has ROIC of -36.90%
- Astra has ROIC of -36.85%
- e-Therapeutics Plc has ROIC of -36.82%
- Adaptimmune Therapeutics Plc has ROIC of -36.80%
- Replimune Inc has ROIC of -36.80%
- Immutep has ROIC of -36.74%
- Immutep has ROIC of -36.74%
- SiteMinder has ROIC of -36.71%
- Cettire has ROIC of -36.68%
- Strongbridge Biopharma plc has ROIC of -36.65%